Studies of the binding properties of influenza hemagglutinin receptor-site mutants.

Site-specific mutations have been made in the influenza hemagglutinin (HA) receptor binding site to assess the contribution of individual amino acid residues to receptor recognition. Screening of mutant HAs, expressed using recombinant vaccinia virus-infected cells, for their abilities to bind human erythrocytes indicated that substitutions involving conserved residues Y98F, H183F, and L194A severely restricted binding and that the substitution W153A prevented cell surface expression of HA. Mutation of residues E190 and S228 that are in positions to form hydrogen bonds with the 9-OH of sialic acid appeared to increase erythrocyte binding slightly, as did the substitution G225R. Substitutions of other residues that are directly or indirectly involved in receptor binding, S136T, S136A, Y195F, G225D, and L226P, had intermediate effects on binding between these two extremes. Estimates of changes in receptor binding specificity based on inhibition of binding to erythrocytes by nonimmune horse sera indicated that mutants G225R and L226P, unlike wild-type HA, were not inhibited; Y195F and G225D mutants were, like wild type, inhibited; and erythrocyte binding by mutants S136A, S136T, E190A, and S228G was only partially inhibited. Viruses containing mutant HAs Y98F, S136T, G225D, and S228G that cover the range of erythrocyte binding properties observed were also constructed by transfection. All four transfectant viruses replicated in MDCK cells and embryonated hens' eggs as efficiently as wild-type X-31 virus, although the Y98F mutant virus was unable to agglutinate erythrocytes. Mutant MDCK cells that have reduced levels of cell surface sialic acids were susceptible to infection by S136T, G225D, and S228G transfectant viruses and by wild type but not by the Y98F transfectant virus.

[1]  I. Wilson,et al.  Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity , 1983, Nature.

[2]  J. Shay.  Techniques in Somatic Cell Genetics , 1982, Springer US.

[3]  Ian A. Wilson,et al.  The structure of the influenza virus haemagglutinin glycoprotein at 3 Ã resolution , 1981 .

[4]  S. Watowich,et al.  Crystal structures of influenza virus hemagglutinin in complex with high-affinity receptor analogs. , 1994, Structure.

[5]  Y. Kawaoka,et al.  Differences in sialic acid-galactose linkages in the chicken egg amnion and allantois influence human influenza virus receptor specificity and variant selection , 1997, Journal of virology.

[6]  T. Kunkel,et al.  Rapid and efficient site-specific mutagenesis without phenotypic selection. , 1987, Methods in enzymology.

[7]  J. Skehel,et al.  The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. , 1987, Annual review of biochemistry.

[8]  J. Skehel,et al.  A surface plasmon resonance assay for the binding of influenza virus hemagglutinin to its sialic acid receptor. , 1996, Virology.

[9]  J. Knowles,et al.  Design and Evaluation of a Tightly Binding Fluorescent Ligand for Influenza A Hemagglutinin. , 1993 .

[10]  M B Eisen,et al.  Binding of the influenza A virus to cell-surface receptors: structures of five hemagglutinin-sialyloligosaccharide complexes determined by X-ray crystallography. , 1997, Virology.

[11]  J. Skehel,et al.  Amantadine selection of a mutant influenza virus containing an acid-stable hemagglutinin glycoprotein: evidence for virus-specific regulation of the pH of glycoprotein transport vesicles. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J. Paulson,et al.  Basis for the potent inhibition of influenza virus infection by equine and guinea pig alpha 2-macroglobulin. , 1989, The Journal of biological chemistry.

[13]  B. Moss,et al.  Selection of recombinant vaccinia viruses on the basis of plaque formation. , 1995, Gene.

[14]  J. Skehel,et al.  Studies of the membrane fusion activities of fusion peptide mutants of influenza virus hemagglutinin , 1995, Journal of virology.

[15]  J. Skehel,et al.  Analyses of the antigenicity of influenza haemagglutinin at the pH optimum for virus-mediated membrane fusion. , 1983, The Journal of general virology.

[16]  I. Wilson,et al.  Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution , 1981, Nature.

[17]  P. Palese,et al.  High-efficiency formation of influenza virus transfectants , 1991, Journal of virology.

[18]  M. Bednarski,et al.  Direct colorimetric detection of a receptor-ligand interaction by a polymerized bilayer assembly. , 1993, Science.

[19]  J. Skehel,et al.  Deacylation of the hemagglutinin of influenza A/Aichi/2/68 has no effect on membrane fusion properties. , 1991, Virology.

[20]  T. Kunkel.  Rapid and efficient site-specific mutagenesis without phenotypic selection. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[21]  E. Rodriguez-Boulan,et al.  Glycosylation does not determine segregation of viral envelope proteins in the plasma membrane of epithelial cells , 1981, The Journal of cell biology.

[22]  G M Whitesides,et al.  Hemagglutinins from two influenza virus variants bind to sialic acid derivatives with millimolar dissociation constants: a 500-MHz proton nuclear magnetic resonance study. , 1989, Biochemistry.

[23]  D. Wiley,et al.  Fusion mutants of the influenza virus hemagglutinin glycoprotein , 1985, Cell.

[24]  R. Webster,et al.  Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. , 1994, Virology.

[25]  I. Wilson,et al.  Sequential mutations in hemagglutinins of influenza B virus isolates: definition of antigenic domains. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[26]  H. Klenk,et al.  Neuraminidase is essential for fowl plague virus hemagglutinin to show hemagglutinating activity. , 1995, Virology.

[27]  K. Simons,et al.  A polarized epithelial cell mutant deficient in translocation of UDP-galactose into the Golgi complex. , 1988, The Journal of biological chemistry.

[28]  J. Skehel,et al.  The receptor‐binding and membrane‐fusion properties of influenza virus variants selected using anti‐haemagglutinin monoclonal antibodies. , 1987, The EMBO journal.

[29]  E. Schreiner,et al.  Use of sialic acid analogues to define functional groups involved in binding to the influenza virus hemagglutinin. , 1992, European journal of biochemistry.

[30]  S. Cusack,et al.  Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid , 1988, Nature.

[31]  J. Skehel,et al.  Binding of influenza virus hemagglutinin to analogs of its cell-surface receptor, sialic acid: analysis by proton nuclear magnetic resonance spectroscopy and X-ray crystallography. , 1994, Biochemistry.